Quintanrix Unione Europea - sloveno - EMA (European Medicines Agency)

quintanrix

glaxosmithkline biologicals s.a. - davica toxoid, tetanus toxoid, inaktivirano bordetella oslovskemu kašlju, hepatitisu b površinski antigen (rdna), haemophilus influenzae tip b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; diphtheria - cepiva - quintanrix je indicirano za primarni imunizaciji dojenčkov (v prvem letu življenja) proti davici, tetanus, oslovski kašelj, hepatitis b in invazivnih bolezni, ki povzroča haemophilus influenzae tipa b in za dvig imunizacije otrok med na drugo leto življenja. uporaba quintanrix je treba določiti na podlagi uradnih priporočil.

Alofisel Unione Europea - sloveno - EMA (European Medicines Agency)

alofisel

takeda pharma a/s - darvadstrocel - rektalna fistula - imunosupresivi - alofisel je primerna za zdravljenje kompleksnih perianalnih fistulas pri odraslih bolnikih z ne-aktivna/lahko aktivno luminal crohnova bolezen, ko fistulas so pokazale, nezadosten odgovor na vsaj eno konvencionalne ali biološke terapije. alofisel je treba uporabiti po kondicioniranje fistula.

Heplisav B Unione Europea - sloveno - EMA (European Medicines Agency)

heplisav b

dynavax gmbh - površinski antigen hepatitisa b - hepatitis b - cepiva - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.

Xevudy Unione Europea - sloveno - EMA (European Medicines Agency)

xevudy

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - imunski sera in imunoglobulini, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.

PreHevbri Unione Europea - sloveno - EMA (European Medicines Agency)

prehevbri

vbi vaccines b.v. - površinski antigen hepatitisa b - hepatitis b - cepiva - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.

Bimervax Unione Europea - sloveno - EMA (European Medicines Agency)

bimervax

hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - cepiva - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.

Fragmin 18.000 i.e./0,72 ml raztopina za injiciranje Slovenia - sloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fragmin 18.000 i.e./0,72 ml raztopina za injiciranje

pfizer luxembourg sarl - natrijev dalteparinat - raztopina za injiciranje - natrijev dalteparinat 25000 i.e. / 1 ml - dalteparin

Fragmin 10.000 i.e./0,4 ml raztopina za injiciranje Slovenia - sloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fragmin 10.000 i.e./0,4 ml raztopina za injiciranje

pfizer luxembourg sarl - natrijev dalteparinat - raztopina za injiciranje - natrijev dalteparinat 25000 i.e. / 1 ml - dalteparin

Fragmin 7.500 i.e./0,3 ml raztopina za injiciranje Slovenia - sloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fragmin 7.500 i.e./0,3 ml raztopina za injiciranje

pfizer luxembourg sarl - natrijev dalteparinat - raztopina za injiciranje - natrijev dalteparinat 25000 i.e. / 1 ml - dalteparin

Fragmin 5.000 i.e./0,2 ml raztopina za injiciranje Slovenia - sloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fragmin 5.000 i.e./0,2 ml raztopina za injiciranje

pfizer luxembourg sarl - natrijev dalteparinat - raztopina za injiciranje - natrijev dalteparinat 25000 i.e. / 1 ml - dalteparin